Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001808
  • SHG: 600329
CNY
35.10
-0.1 (-0.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Why is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. ?

1
Poor Management Efficiency with a low ROCE of 13.54%
  • The company has been able to generate a Return on Capital Employed (avg) of 13.54% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of -5.98% and Operating profit at 7.66% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 15.94% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -5.98% and Operating profit at 7.66% over the last 5 years
4
With a fall in Net Sales of -38%, the company declared Very Negative results in Jun 26
  • The company has declared negative results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 905.84 MM
  • PRE-TAX PROFIT(Q) At CNY 252.58 MM has Fallen at -60.44%
  • NET PROFIT(Q) At CNY 220.94 MM has Fallen at -59.47%
5
With ROE of 28.74%, it has a fair valuation with a 3.23 Price to Book Value
  • Over the past year, while the stock has generated a return of NA, its profits have fallen by -1.9%
  • At the current price, the company has a high dividend yield of 8.7
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
0.0%
-0.14
30.72%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-5.98%
EBIT Growth (5y)
7.66%
EBIT to Interest (avg)
74.54
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.85
Tax Ratio
15.00%
Dividend Payout Ratio
173.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.84%
ROE (avg)
15.94%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
3.23
EV to EBIT
25.93
EV to EBITDA
23.37
EV to Capital Employed
3.89
EV to Sales
4.54
PEG Ratio
NA
Dividend Yield
8.75%
ROCE (Latest)
15.01%
ROE (Latest)
28.74%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
NO KEY POSITIVE TRIGGERS
-30What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 905.84 MM

PRE-TAX PROFIT(Q)

At CNY 252.58 MM has Fallen at -60.44%

NET PROFIT(Q)

At CNY 220.94 MM has Fallen at -59.47%

INTEREST(HY)

At CNY 5.18 MM has Grown at 7.29%

ROCE(HY)

Lowest at 11.52%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.07 times

NET SALES(Q)

Lowest at CNY 939.39 MM

Here's what is not working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Net Sales
At CNY 939.39 MM has Fallen at -24.51%
over average net sales of the previous four periods of CNY 1,244.31 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 252.58 MM has Fallen at -60.44%
over average net sales of the previous four periods of CNY 638.4 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 220.94 MM has Fallen at -59.47%
over average net sales of the previous four periods of CNY 545.14 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 905.84 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 5.18 MM has Grown at 7.29%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio
Lowest at 1.07 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales
Lowest at CNY 939.39 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Footer loading